Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seynaeve

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|July 21, 2001
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutationH Meijers-Heijboer, B van Geel, W L van Putten, et al.
European Journal of Human Genetics : EJHG|August 2, 2003
Possible consequences of applying guidelines to healthy women with a family history of breast cancerC J van Asperen, R A E M Tollenaar, E M M Krol-Warmerdam, et al.
Journal of Medical Genetics|October 7, 2004
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantG H de Bock, M Schutte, E M M Krol-Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancerC T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
British Journal of Cancer|October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancerJ Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapyC Seynaeve, L C Verhoog, L M C van de Bosch, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|July 21, 2001
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutationH Meijers-Heijboer, B van Geel, W L van Putten, et al.
European Journal of Human Genetics : EJHG|August 2, 2003
Possible consequences of applying guidelines to healthy women with a family history of breast cancerC J van Asperen, R A E M Tollenaar, E M M Krol-Warmerdam, et al.
Journal of Medical Genetics|October 7, 2004
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantG H de Bock, M Schutte, E M M Krol-Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancerC T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
British Journal of Cancer|October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancerJ Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapyC Seynaeve, L C Verhoog, L M C van de Bosch, et al.
Pageof 11